CKD
Advertisement
Treatment with a finerenone-empagliflozin combo leads to greater decreases in albuminuria in CKD and type 2 diabetes.
A study highlights the role of NPT2b in tubulointerstitial fibrosis and CKD progression.
A dual SGLT inhibitor may have ischemic benefits for patients with CKD, T2D, and cardiovascular risks, a study found.
An analysis of CKD trials supported 3-year total slope as the primary slope-based outcome in randomized trials.
A study assessed whether proton pump inhibitor use accelerated CKD progression and acute kidney injury risk.
A survey sought insight on nephrologists' practices and perceptions about reproductive care for women with kidney disease.
Researchers presented results of an interim analysis of a study of finerenone among patients with CKD and type 2 diabetes.
Researchers assessed the burden of cardiovascular-kidney-metabolic (CKM) syndrome using NHANES 2001-2020 data.
A study examined the association of ankle-brachial index and CKD progression with type 2 diabetes and elevated BMI.
Could a combined nutritional supplementation and exercise training program improve frailty and health outcomes with CKD?
The Freely Filtered Filtrate discusses the top nephrology stories of 2024, including FLOW, cyberattacks, and IgAN trials.
A study examined whether kidney function decline accelerated after COVID-19 versus other respiratory infections.
A study evaluated the effectiveness of spironolactone for reducing adverse cardiovascular outcomes in older adults with CKD.
Researchers studied the efficacy of exercise in improving cognitive function in people with CKD and its potential harm.
SC0062 met the 12-week primary end point of a reduction in proteinuria in a study cohort with diabetic kidney disease (DKD).
A study examined MPS-based gene panel testing in patients with unexplained CKD in a real-world context.
Previous studies suggest a link between CKD and sleep disorders, but the nature of the association is unclear.
Using NURTuRE-CKD data, researchers studied kidney outcomes and heterogeneity of risk by primary renal diagnosis.
Researchers summarized findings on dietary interventions to reduce acid load to manage metabolic acidosis in adults with CKD.
The EMPA-KIDNEY trial examined the effects of SGLT2 inhibition on uric acid and gout in patients with CKD.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.